EcoDrugPlus

Ensembl ID : WBGene00234131
Gene Symbol: WBGENE00234131
4 External references
74 Possible Orthologues:

Ensembl ID : WBGene00234143
Gene Symbol: WBGENE00234143
4 External references
114 Possible Orthologues:

Ensembl ID : WBGene00234149
Gene Symbol: WBGENE00234149
6 External references
117 Possible Orthologues:

Ensembl ID : WBGene00234154
Gene Symbol: WBGENE00234154
6 External references
94 Possible Orthologues:

Ensembl ID : WBGene00234157
Gene Symbol: WBGENE00234157
6 External references
108 Possible Orthologues:

Ensembl ID : WBGene00234159
Gene Symbol: WBGENE00234159
5 External references
107 Possible Orthologues:

Ensembl ID : WBGene00234162
Gene Symbol: WBGENE00234162
4 External references
137 Possible Orthologues:

Ensembl ID : WBGene00234163
Gene Symbol: WBGENE00234163
4 External references
209 Possible Orthologues:

Ensembl ID : WBGene00234166
Gene Symbol: WBGENE00234166
6 External references
97 Possible Orthologues:

Ensembl ID : WBGene00234202
Gene Symbol: WBGENE00234202
6 External references
196 Possible Orthologues:

Ensembl ID : WBGene00234258
Gene Symbol: WBGENE00234258
6 External references
73 Possible Orthologues:

Ensembl ID : WBGene00234268
Gene Symbol: WBGENE00234268
5 External references
111 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).